Bupropion Hydrochloride

盐酸安非他酮

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameBupropion Hydrochloride
Drug Alias NameBupropion安非布他酮Bupropione叔丁胺苯丙酮盐酸丁氨苯丙酮 +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsAdrenergic receptors antagonists
TargetsDopamine transporterAdrenergic receptors
Therapy Area/IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Oral Squamous Cell CarcinomaApathy in Dementia +[53] 
Global Approved IndicationsDepressive Disorder, MajorDepression
Approved Indications in ChinaDepression
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/30
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Gmbh & Co. KgUT Health San AntonioUniversity Of Rochester +[8] 
Inactive CompaniesCanadian Institutes Of Health Research (Cihr)SandozUniversity Medical Center Goettingen +[32] 
Active IndicationsSolid tumoursSeasonal Affective DisorderBinge-Eating Disorder +[11] 
Inactive IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Oral Squamous Cell CarcinomaApathy in Dementia +[42] 

Other Information

ATC CodeN06AX12
Related LinksWikipediaDrugBankKEGG